Waldmeier PC[au] - Search Results

Year	Number of Results
1974	1
1975	2
1976	6
1977	4
1978	5
1979	6
1980	4
1981	6
1982	4
1983	9
1984	6
1985	3
1986	2
1987	3
1988	4
1989	3
1990	6
1991	2
1992	4
1993	8
1994	2
1995	2
1996	4
1998	1
2000	4
2002	1
2003	2
2004	1
2005	1
2007	2
2008	1
2022	0

1

Presynaptic GABA receptors.

Waldmeier PC, Baumann PA. Waldmeier PC, et al. Ann N Y Acad Sci. 1990;604:136-51. doi: 10.1111/j.1749-6632.1990.tb31989.x. Ann N Y Acad Sci. 1990. PMID: 2171392 Review. No abstract available.

2

Cyclophilin D as a drug target.

Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ. Waldmeier PC, et al. Curr Med Chem. 2003 Aug;10(16):1485-506. doi: 10.2174/0929867033457160. Curr Med Chem. 2003. PMID: 12871122 Review.

3

Prospects for antiapoptotic drug therapy of neurodegenerative diseases.

Waldmeier PC. Waldmeier PC. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):303-21. doi: 10.1016/S0278-5846(03)00025-3. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12657369 Review.

4

Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?

Waldmeier PC, Tatton WG. Waldmeier PC, et al. Drug Discov Today. 2004 Mar 1;9(5):210-8. doi: 10.1016/S1359-6446(03)03000-9. Drug Discov Today. 2004. PMID: 14980539 Review.

5

Brofaromine--a review of its pharmacological properties and therapeutic use.

Volz HP, Gleiter CH, Waldmeier PC, Struck M, Möller HJ. Volz HP, et al. Among authors: waldmeier pc. J Neural Transm (Vienna). 1996;103(1-2):217-45. doi: 10.1007/BF01292628. J Neural Transm (Vienna). 1996. PMID: 9026374 Review.

6

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?

Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. Sullivan PG, et al. Among authors: waldmeier pc. J Neurosci Res. 2005 Jan 1-15;79(1-2):231-9. doi: 10.1002/jnr.20292. J Neurosci Res. 2005. PMID: 15573402 Review.

7

Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine.

Waldmeier PC. Waldmeier PC. Prog Neuropsychopharmacol Biol Psychiatry. 1993 Mar;17(2):183-98. doi: 10.1016/0278-5846(93)90042-q. Prog Neuropsychopharmacol Biol Psychiatry. 1993. PMID: 8430214 Review.

8

Basic and clinical aspects of the activity of the new monoamine oxidase inhibitors.

Delini-Stula A, Radeke E, Waldmeier PC. Delini-Stula A, et al. Among authors: waldmeier pc. Psychopharmacol Ser. 1988;5:147-58. doi: 10.1007/978-3-642-73280-5_14. Psychopharmacol Ser. 1988. PMID: 3045798 Review.

9

Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain).

Waldmeier PC. Waldmeier PC. J Neural Transm Suppl. 1987;23:55-72. doi: 10.1007/978-3-7091-8901-6_4. J Neural Transm Suppl. 1987. PMID: 3108453 Review.

10

Effects of chronic antidepressant treatment on pre- and post-synaptic dopaminergic mechanisms. A short review of the literature and some complementary experiments.

Waldmeier PC. Waldmeier PC. Pol J Pharmacol Pharm. 1984 Mar-Jun;36(2-3):201-16. Pol J Pharmacol Pharm. 1984. PMID: 6147829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results